Complete GTBP Stock Valuation Analysis
Comprehensive intrinsic value analysis using 1 different methodologies
GTBP Peer Valuation Analysis
Relative valuation based on comparable company trading multiples
Peer Valuation Analysis
Fair Value Range Analysis
Based on median multiples from 8 peer companies in Healthcare
P/E Ratio
$-1.76
-147.4%
Peer Median: 0.4x
EV/EBITDA
$0.00
-100.0%
Peer Median: 0.0x
P/S Ratio
$0.00
-100.0%
Peer Median: 1.1x
Interpretation: Each multiple provides a different perspective on fair value. Consider which multiple is most relevant for GTBP's business model and current situation.
Multiple Comparison
| Multiple | GTBP Current | Peer Median | Peer Average | Premium/Discount | Assessment |
|---|---|---|---|---|---|
| P/E Ratio | -0.7x | 0.4x | 0.4x | -310.8% | Undervalued |
| EV/EBITDA | Infinityx | 0.0x | 0.0x | Infinity% | Overvalued |
| P/S Ratio | Infinityx | 1.1x | 1.5x | Infinity% | Overvalued |
Peer Companies
Click any company to view their valuation
| Company | Market Cap | P/E Ratio | EV/EBITDA | P/S Ratio |
|---|---|---|---|---|
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 0.3x | |
| $0.01B | 0.0x | 0.0x | 1.1x | |
| $0.01B | 0.0x | 0.0x | 687.5x | |
| $0.01B | 0.0x | 0.0x | 0.0x | |
| $0.01B | 0.0x | 0.0x | 286.6x | |
| $0.01B | 0.0x | 0.0x | 3.1x | |
| $0.01B | 0.4x | 0.0x | 0.0x |